Literature DB >> 30079974

The many faces of lung adenocarcinoma: A pictorial essay.

Heather M Pascoe1, Henry C Knipe1, Diane Pascoe1, Stefan B Heinze1.   

Abstract

Lung adenocarcinoma has a spectrum of appearances on CT, many of which mimic non-malignant processes. The general radiologist has a major role in guiding the management of abnormalities detected on chest CT and an awareness of these appearances is vital. We describe the protean imaging manifestations of lung adenocarcinoma.
© 2018 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Keywords:  adenocarcinoma; computed tomography; lung cancer; non-neoplastic pulmonary disease

Mesh：

Year:  2018        PMID： 30079974     DOI： 10.1111/1754-9485.12779

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN： 1754-9477            Impact factor:   1.735


  12 in total

1.  Mechanism of transmembrane and coiled-coil domain 1 in the regulation of proliferation and migration of A549 cells.

Authors:  Chen Yang; Yuan Wang; Jian-Qi Bai; Jing-Ru Zhang; Pei-Yan Hu; Yan Zhu; Qin Ouyang; Hong-Mei Su; Qiu-Yue Li; Ping Zhang
Journal:  Oncol Lett       Date:  2020-08-26       Impact factor: 2.967

2.  Support Vector Machine for Lung Adenocarcinoma Staging Through Variant Pathways.

Authors:  Feng Di; Chunxiao He; Guimei Pu; Chunyi Zhang
Journal:  G3 (Bethesda)       Date:  2020-07-07       Impact factor: 3.154

3.  Multiple endocrinological failures as a clinical presentation of a metastatic lung adenocarcinoma.

Authors:  Taieb Ach; Perrine Wojewoda; Flora Toullet; Roxane Ducloux; Véronique Avérous
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-04-29

4.  Is the combination of bilateral pulmonary nodules and mosaic attenuation on chest CT specific for DIPNECH?

Authors:  Bilal F Samhouri; Chi Wan Koo; Eunhee S Yi; Jay H Ryu
Journal:  Orphanet J Rare Dis       Date:  2021-11-22       Impact factor: 4.123

5.  Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway.

Authors:  Ziheng Li; Ying Zhang; Yuan Zhou; Fuqian Wang; Chao Yin; Li Ding; Shunbo Zhang
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.379

6.  Differential diagnosis of localized pneumonic-type lung adenocarcinoma and pulmonary inflammatory lesion.

Authors:  Qi Li; Xiao Fan; Ji-Wen Huo; Tian-You Luo; Xing-Tao Huang; Jun-Wei Gong
Journal:  Insights Imaging       Date:  2022-03-22

7.  Efficacy and Safety of Gefitinib Plus Pemetrexed/Platinum in Advanced EGFR-Mutated Lung Adenocarcinoma Patients: A Real-World Observational Study.

Authors:  Rui Wang; Qiang Wu
Journal:  Onco Targets Ther       Date:  2022-01-13       Impact factor: 4.345

Review 8.  Molecular typing of lung adenocarcinoma with computed tomography and CT image-based radiomics: a narrative review of research progress and prospects.

Authors:  Jing-Wen Ma; Meng Li
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

9.  Computed Tomography Morphological Classification of Lung Adenocarcinoma and Its Correlation with Epidermal Growth Factor Receptor Mutation Status: A Report of 1075 Cases.

Authors:  Xiao-Qun He; Xing-Tao Huang; Qi Li; Xiao Fan; Tian-You Luo; Ji-Wen Huo
Journal:  Int J Gen Med       Date:  2021-07-21

10.  [CCL18 Promotes the Invasion of Lung Adenocarcinoma through ANXA2].

Authors:  Zikun Deng; Qinpei Xiao; Yuanhang Zheng; Ruijun Feng; Zhimei Sheng; Baogang Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.